Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FXUC0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,656
Award facts
- Contract value 100% obligated
- $10,655.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,655.60 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) on January 15, 2026, with an ultimate completion date of January 16, 2026. This competitively awarded, firm fixed-price delivery order was placed against AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031). The place of performance is listed as Conshohocken, Pennsylvania, where the prime contractor maintains its corporate headquarters. No set-aside designation was applied to this contract award.
This delivery order represents a routine pharmaceutical procurement within AmerisourceBergen's extensive portfolio of medical supply deliveries to federal military and healthcare systems. Gemtesa (mirabegron) is a medication used to treat overactive bladder, and this order fulfills an immediate pharmaceutical need within the Defense Health Agency or related military treatment facility network. AmerisourceBergen's role as a critical pharmaceutical distributor for federal procurement enables the efficient delivery of specialized medical commodities across multiple therapeutic domains to support military personnel and veteran healthcare programs globally. The short completion timeline reflects the standard expedited delivery typical of pharmaceutical resupply orders for active medical operations.
Quick answers
Who was awarded contract SPE2DR26FXUC0?
SPE2DR26FXUC0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FXUC0 worth?
The government has obligated $10,656 on SPE2DR26FXUC0.
Is contract SPE2DR26FXUC0 an order under another contract?
Yes. SPE2DR26FXUC0 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUC0 competed?
The extent of competition for SPE2DR26FXUC0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award